Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02297009
Other study ID # S57170
Secondary ID
Status Recruiting
Phase N/A
First received October 31, 2014
Last updated January 13, 2015
Start date December 2014
Est. completion date September 2018

Study information

Verified date October 2014
Source Universitaire Ziekenhuizen Leuven
Contact Kirsten Van Landuyt, Prof. Dr
Email kirsten.vanlanduyt@med.kuleuven.be
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Observational

Clinical Trial Summary

A buccal swab will be taken using a cotton stick by rubbing it against the buccal mucosa. Samples will be taken from the same participant at different timepoints.

DNA will be extracted from the buccal cells on the swabs using a commercial extraction kit and will be quantified by a nano-drop spectrophotometer.

We will determine global and gene-specific methylation and hydroxymethylation alterations by UPLC/MS/MS. Hydrolyzed DNA into individual nucleosides will be analyzed for the quantitative measurement of 5-methylCytosine and 5-hydroxymethylCytosine on Triple Quadrupole UPLC/MS/MS platform. Secondly, specific methylation in the CpG islands of tumor suppressor and promoter genes, and genes involved in the oxidative stress pathways will be assessed by PCR-pyrosequencing.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 2018
Est. primary completion date June 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Caucasian

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Buccal swab
Buccal swabs will be taken from the volunteers

Locations

Country Name City State
Belgium BIOMAT Leuven

Sponsors (2)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven Katholieke Universiteit Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary %Methylation (%) 5 weeks No
Secondary %Hydroxymethylation (%) 5 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03642574 - Preimplantation DNA Methylation Test (PIMT) in ART N/A
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Recruiting NCT05442125 - First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization N/A
Recruiting NCT05624827 - The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2) N/A
Completed NCT05085847 - Effects of Mindfulness-based Intervention on Epigenetic Mechanisms, Cognition Function, Stress Response, and Well-being N/A
Recruiting NCT04651946 - Cell-free DNA Methylation for Epithelial Ovarian Cancer Phase 2
Recruiting NCT04646954 - DNA Methylation Testing for the Screening of Uterine Cervical Lesion Phase 3
Recruiting NCT03961191 - DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
Not yet recruiting NCT05779904 - Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of Stunted Children
Recruiting NCT05791149 - Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity N/A
Recruiting NCT05801263 - ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting NCT05801276 - ctDNA Methylation for Detecting Ovarian Cancer
Recruiting NCT05290415 - Host DNA Methylation for Endometrial Cancer Screening
Recruiting NCT05290428 - DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening
Recruiting NCT05290922 - DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening
Recruiting NCT03960879 - DNA Methylation for Screening Uterine Cervical Lesions
Recruiting NCT05737953 - Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
Recruiting NCT06140992 - PaCIFiC-CUP Classifies Cancer of Unknown Primary
Completed NCT02032628 - DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise N/A
Completed NCT04568512 - DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture N/A